All Infection Prevention & Control articles
-
NewsNew one-two punch could knock out drug-resistant TB
Researchers found that pairing the antibiotic rifampicin with a second compound turned multidrug resistance into a weakness—providing proof of concept for using basic science to design life-saving dual-drug strategies.
-
NewsA new way to diagnose deadly lung infections and save lives
Researchers have found a way to identify lung infections in critically ill patients by pairing a generative AI analysis of medical records with a biomarker of lower respiratory infections.
-
NewsNew method accelerates resistance testing in urinary tract infections
Researchers have developed two methods that allow urine samples to be tested directly for antibiotic susceptibility. Because the procedures do not require standardized bacterial suspensions, the time to result is reduced by up to 24 hours compared to conventional testing.
-
CareersCBCTA 2024 oral presentation winners: Isabella and Lia take home the honours
Letters in Applied Microbiology sponsored the best oral presentation award at the 29th Brazilian Congress of Food Science and Technology (CBCTA 2024). Winner Isabella Bassoto Xavier and runner-up Lia Mariano Aquino take a dive into their research.
-
NewsStudy uncovers new drug target for huge class of viruses
A study reveals how enteroviruses—including pathogens that cause polio, encephalitis, myocarditis, and the common cold—initiate replication by hijacking host-cell machinery.
-
NewsOroya fever: Elucidation of disease mechanism opens possibility for novel therapy
An international research team has generated and analyzed more than 1,700 genetic variants of the pathogen that causes Oroya fever, identifying two proteins that Bartonella requires for the destruction of red blood cells.
-
NewsNew method means contaminated bathing water easier to detect
A new method can provide both faster and more complete answers on whether the water is safe for swimming or not. The innovation has been successfully tested in Helsingborg, where the response time has been reduced from several days to just a few hours.
-
NewsStrategic advancement of second-generation fungal vaccine VXV-01 through Phase 1 trials
The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) have announced that the second-generation fungal vaccine candidate known as VXV‑01 is poised to move forward in development up to and including Phase 1 clinical evaluation.
-
NewsA testing paradox for sexually transmitted infections
Surveillance evidence shows an increase in people infected with other STIs after initiating PrEP. A new study provides a counterintuitive explanation revealing a testing paradox: even when the observed cases increase, the true numbers of STIs can decrease.
-
NewsModulating key interaction prevents virus from entering cells
Researchers have found a way to modulate a common virus protein to prevent viruses from entering cells where it can cause illness. They were able to find and block an important interaction at the molecular level that allows the herpes virus to enter cells.
-
NewsImmune system keeps mucosal fungi in check
Researchers investigating the mechanisms that keep the fungus under control on our mucosa shed light on how homeostasis is maintained through the fine-tuned interplay between Candida albicans and the epithelial barrier on the one hand, and the immune system on the other hand.
-
NewsStreptococcus suis serotype 2 collagenase-like protease promotes meningitis by increasing blood-brain barrier permeability
Streptococcus suis serotype 2 (SS2) is an emerging zoonotic pathogen that causes meningitis in humans and pigs. Researchers have investigated the role and mechanism of the SS2 Clp in promoting the passage of the bacterium across the blood-brain barrier (BBB).
-
NewsHarmless Klebsiella strain shows powerful protection against gut infections in Inflammatory Bowel Disease (IBD) model
A new study demonstrates that a harmless strain of Klebsiella can eliminate infections and reduce gut inflammation in mouse models of inflammatory bowel disease (IBD).
-
NewsStudy links gut bacteria to bloodstream infections in newborns within sub-Saharan Africa for the first time
New research has shown gut and bloodstream infections are caused by the same bacteria giving hope of better prevention and diagnosis of deadly neonatal sepsis.
-
NewsCould hidden infections be fueling long COVID?
For millions suffering from long COVID, their persistent breathlessness, brain fog and fatigue remain a maddening mystery, but microbiologists think they may have cracked the case. The review argues that co-infections acquired before or during COVID could cause symptoms to persist indefinitely for many people.
-
NewsApplications of AI in antimicrobial resistance prevention and control
Researchers have published a review shedding light on how AI is revolutionizing the prevention and control of AMR. The article illustrates how machine learning and deep learning are transforming surveillance, diagnosis, treatment optimization, and drug discovery.
-
NewsGlobal Virus Network announces appointment of new board members
The Global Virus Network (GVN), a worldwide coalition of leading human and animal virologists, has announced the appointment of eight distinguished leaders to its Board of Directors.
-
NewsScalable nanoengineered gauze with sustained natural product release
A multi-institutional Chinese research team has developed PPCZ@Gauze – a novel nanoengineered dressing that synergistically combines antibacterial, anti-adhesive, and pro-angiogenic functions.
-
NewsUnique bond identified as key to viral infection speed
Viruses are typically described as tiny, perfectly geometric shells that pack genetic material with mathematical precision, but new research reveals a deliberate imbalance in their shape that helps them infect their hosts.
-
NewsResearchers discover how Ebola and Marburg disrupt the gastrointestinal tract
A new study sheds light on the mechanisms behind the damage caused by Ebola (EBOV) and Marburg virus (MARV) to the gastrointenstinal tract. TIt found that both viruses are capable of infecting and replicating within human gut epithelial cells and that the viruses interfere with the cells’ ability to regulate fluid secretion, mirroring the severe symptoms observed in patients.